Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention (Q34366988)

1 August 2017

Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention (English)

1 reference

1 August 2017

0 references

0 references

S S Pattni

1

1 reference

1 August 2017

W G Brydon

2

1 reference

1 August 2017

T Dew

3

1 reference

1 August 2017

J D Nolan

5

1 reference

1 August 2017

M Srinivas

6

1 reference

1 August 2017

P Basumani

7

1 reference

1 August 2017

K D Bardhan

8

1 reference

1 August 2017

J R F Walters

9

1 reference

1 August 2017

I M Johnston

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

27 August 2013

1 reference

Alimentary Pharmacology & Therapeutics

1 August 2017

1 reference

1 August 2017

38

1 reference

1 August 2017

967-976

1 reference

1 August 2017

8

1 reference

Recent advances in the understanding of bile acid malabsorption

1 August 2017

1 reference

Cholestyramine treatment of diarrhea associated with ileal resection

21 January 2018

1 reference

Managing bile acid diarrhoea

21 January 2018

1 reference

Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder.

21 January 2018

1 reference

Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.

21 January 2018

1 reference

Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms.

21 January 2018

1 reference

Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea.

21 January 2018

1 reference

Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea

21 January 2018

1 reference

Bile acid malabsorption as a cause of chronic diarrhea: diagnostic value of 7alpha-hydroxy-4-cholesten-3-one in serum

21 January 2018

1 reference

An evaluation of the use of serum 7-alpha-hydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea

21 January 2018

1 reference

Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea

21 January 2018

1 reference

A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis

21 January 2018

1 reference

Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release

21 January 2018

1 reference

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

21 January 2018

1 reference

Primary bile acid diarrhoea without an ileal carrier defect: quantification of active bile acid transport across the ileal brush border membrane

21 January 2018

1 reference

Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption.

21 January 2018

1 reference

FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption

21 January 2018

1 reference

Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys

21 January 2018

1 reference

A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea

21 January 2018

1 reference

Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea.

21 January 2018

1 reference

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

21 January 2018

1 reference

Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19.

21 January 2018

1 reference

Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function

21 January 2018

1 reference

Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis

21 January 2018

1 reference

Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum

21 January 2018

1 reference

Indirect evidence for increased mechanosensitivity of jejunal secretomotor neurones in patients with idiopathic bile acid malabsorption.

21 January 2018

1 reference

FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis

21 January 2018

1 reference

Bile acid malabsorption investigated by selenium-75-homocholic acid taurine ((75)SeHCAT) scans: causes and treatment responses to cholestyramine in 298 patients with chronic watery diarrhoea

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12466

1 reference

1 August 2017

1 reference